Stocks and Investing Stocks and Investing
Wed, June 15, 2022
Tue, June 14, 2022

Neena Bitritto-Garg Maintained (AMLX) at Strong Buy with Increased Target to $33 on, Jun 14th, 2022


Published on 2024-10-27 21:30:46 - WOPRAI, Neena Bitritto-Garg
  Print publication without navigation


Neena Bitritto-Garg of Citigroup, Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy with Increased Target from $32 to $33 on, Jun 14th, 2022.

Neena has made no other calls on AMLX in the last 4 months.



There are 2 other peers that have a rating on AMLX. Out of the 2 peers that are also analyzing AMLX, 1 agrees with Neena's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $10 on, Friday, April 1st, 2022


This is the rating of the analyst that currently disagrees with Neena


  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $31 on, Thursday, March 31st, 2022

Contributing Sources